Drug-Induced Hypophosphatemia: Current Insights Efstathia MegapanouMatilda FlorentinGeorge Liamis Review Article 27 November 2019 Pages: 197 - 210
Prenatal Exposure to Macrolides and Risk of Congenital Malformations: A Meta-Analysis Narmeen MallahHamid Reza TohidinikBahi Takkouche Systematic Review 12 November 2019 Pages: 211 - 221
Fatal Toxicity Indices for Medicine-Related Deaths in New Zealand, 2008–2013 John S. FountainAndrew M. TomlinMurray W. Tilyard Original Research Article 20 November 2019 Pages: 223 - 232
Cardiac Safety of the Trastuzumab Biosimilar ABP 980 in Women with HER2-Positive Early Breast Cancer in the Randomized, Double-Blind, Active-Controlled LILAC Study Hans-Christian KolbergMarco ColleoniVladimir Hanes Original Research Article Open access 11 January 2020 Pages: 233 - 242
Contribution of Causality Assessment for an Automated Detection of Safety Signals: An Example Using the French Pharmacovigilance Database Thomas BerbainAntoine ParienteThe French Network of Pharmacovigilance Centres Original Research Article 23 January 2020 Pages: 243 - 253
The UK BIO-TRAC Study: A Cross-Sectional Study of Product and Batch Traceability for Biologics in Clinical Practice and Electronic Adverse Drug Reaction Reporting in the UK Kevin KleinLorna HazellSaad Shakir Original Research Article Open access 23 December 2019 Pages: 255 - 263
Brand-Specific Enhanced Safety Surveillance of GSK’s Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany and Spain for the 2018/2019 Season Gael Dos SantosBach-Yen NguyenAnne Yeakey Original Research Article Open access 28 December 2019 Pages: 265 - 279
Spontaneous Fluctuations in Liver Biochemistries in Patients with Compensated NASH Cirrhosis: Implications for Drug Hepatotoxicity Monitoring Hani ShamseddeenEduardo Vilar-GomezEric S. Orman Original Research Article 06 January 2020 Pages: 281 - 290
Insight into the Severity of Adverse Drug Reactions as Experienced by Patients Leàn RolfesMichelle HaaksmanEugène van Puijenbroek Research Letter 13 December 2019 Pages: 291 - 293
Follow-Up on the Use of Machine Learning in Clinical Quality Assurance: Can We Detect Adverse Event Under-Reporting in Oncology Trials? Timothé MénardBjörn KoneswarakanthaRich Bowling Research Letter Open access 13 December 2019 Pages: 295 - 296